136 related articles for article (PubMed ID: 30903570)
1. Healthcare utilization and costs among patients with non-functioning pituitary adenomas.
Lobatto DJ; van den Hout WB; Zamanipoor Najafabadi AH; Steffens ANV; Andela CD; Pereira AM; Peul WC; van Furth WR; Biermasz NR; Vliet Vlieland TPM
Endocrine; 2019 May; 64(2):330-340. PubMed ID: 30903570
[TBL] [Abstract][Full Text] [Related]
2. Healthcare utilization and costs among prolactinoma patients: a cross-sectional study and analysis of determinants.
van der Meulen M; Zamanipoor Najafabadi AH; Lobatto DJ; van den Hout WB; Andela CD; Zandbergen IM; Pereira AM; van Furth WR; Vliet Vlieland TPM; Biermasz NR
Pituitary; 2021 Feb; 24(1):79-95. PubMed ID: 33025546
[TBL] [Abstract][Full Text] [Related]
3. The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-Pituitary.
Andela CD; Scharloo M; Ramondt S; Tiemensma J; Husson O; Llahana S; Pereira AM; Kaptein AA; Kamminga NG; Biermasz NR
Pituitary; 2016 Jun; 19(3):293-302. PubMed ID: 26809957
[TBL] [Abstract][Full Text] [Related]
4. Work disability and its determinants in patients with pituitary tumor-related disease.
Lobatto DJ; Steffens ANV; Zamanipoor Najafabadi AH; Andela CD; Pereira AM; van den Hout WB; Peul WC; Vliet Vlieland TPM; Biermasz NR; van Furth WR
Pituitary; 2018 Dec; 21(6):593-604. PubMed ID: 30288666
[TBL] [Abstract][Full Text] [Related]
5. Healthcare cost and survival in patients with non-functioning pituitary adenoma.
Olsson DS; Svensson M; Labori F; De Geer A; Johannsson G
Eur J Endocrinol; 2023 Jun; 188(6):477-484. PubMed ID: 37232269
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in patients with non-functioning pituitary adenoma: a special focus on hydrocortisone replacement dose.
Wild CM; Stieg M; Stalla GK; Auer MK; Athanasoulia-Kaspar AP
Qual Life Res; 2020 Dec; 29(12):3325-3331. PubMed ID: 32737686
[TBL] [Abstract][Full Text] [Related]
7. Quality of life is significantly impaired in both secretory and non-functioning pituitary adenomas.
Vega-Beyhart A; Enriquez-Estrada VM; Bello-Chavolla OY; Torres-Victoria TR; Martínez-Sánchez FD; López-Navarro JM; Pérez-Guzmán MC; Hinojosa-Amaya JM; León-Suárez A; Espinoza-Salazar HD; Roldán-Sarmiento P; Gómez-Sámano MA; Gómez-Pérez FJ; Cuevas-Ramos D
Clin Endocrinol (Oxf); 2019 Mar; 90(3):457-467. PubMed ID: 30548674
[TBL] [Abstract][Full Text] [Related]
8. Quality of Life but not Cognition is Impacted by Radiotherapy in Patients with Non-Functioning Pituitary Adenoma.
Crouzeix G; Morello R; Thariat J; Morera J; Joubert M; Reznik Y
Horm Metab Res; 2019 Mar; 51(3):178-185. PubMed ID: 30861564
[TBL] [Abstract][Full Text] [Related]
9. Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up.
Huynh KA; Coopmans EC; Zamanipoor Najafabadi AH; Dirven L; Peerdeman SM; Biermasz NR; Verstegen MJT; van Furth WR;
J Neurooncol; 2023 Jan; 161(2):357-370. PubMed ID: 36626042
[TBL] [Abstract][Full Text] [Related]
10. Health Literacy Impact on National Healthcare Utilization and Expenditure.
Rasu RS; Bawa WA; Suminski R; Snella K; Warady B
Int J Health Policy Manag; 2015 Aug; 4(11):747-55. PubMed ID: 26673335
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life and unmet healthcare needs in Huntington's disease.
van Walsem MR; Howe EI; Ruud GA; Frich JC; Andelic N
Health Qual Life Outcomes; 2017 Jan; 15(1):6. PubMed ID: 28069034
[TBL] [Abstract][Full Text] [Related]
12. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
13. Health care resource use, health care expenditures and absenteeism costs associated with osteoarthritis in US healthcare system.
Menon J; Mishra P
Osteoarthritis Cartilage; 2018 Apr; 26(4):480-484. PubMed ID: 29269328
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality-of-life, work productivity, and economic burden among patients with Parkinson's disease in Japan.
Yamabe K; Liebert R; Flores N; Pashos C
J Med Econ; 2018 Dec; 21(12):1206-1212. PubMed ID: 30200795
[TBL] [Abstract][Full Text] [Related]
15. Healthcare utilization and costs in chronic cough.
Cho PSP; Shearer J; Simpson A; Campbell S; Pennington M; Birring SS
Curr Med Res Opin; 2022 Jul; 38(7):1251-1257. PubMed ID: 35440252
[TBL] [Abstract][Full Text] [Related]
16. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
[TBL] [Abstract][Full Text] [Related]
17. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P
Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
[TBL] [Abstract][Full Text] [Related]
18. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
19. Assessing the cost of contemporary pituitary care.
McLaughlin N; Martin NA; Upadhyaya P; Bari AA; Buxey F; Wang MB; Heaney AP; Bergsneider M
Neurosurg Focus; 2014 Nov; 37(5):E7. PubMed ID: 26223274
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A as serum marker of pituitary adenomas.
Gussi IL; Young J; Baudin E; Bidart JM; Chanson P
Clin Endocrinol (Oxf); 2003 Nov; 59(5):644-8. PubMed ID: 14616890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]